These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18950279)

  • 1. Skeletal accumulation of bisphosphonates: implications for osteoporosis treatment.
    Allen MR
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1371-8. PubMed ID: 18950279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
    Endo Y; Funayama H; Yamaguchi K; Monma Y; Yu Z; Deng X; Oizumi T; Shikama Y; Tanaka Y; Okada S; Kim S; Kiyama T; Bando K; Shima K; Suzuki H; Takahashi T
    Yakugaku Zasshi; 2020; 140(1):63-79. PubMed ID: 31902887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 4. Alveolar bone and the bisphosphonates.
    Cheng A; Daly CG; Logan RM; Stein B; Goss AN
    Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM
    J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis.
    Zahrowski JJ
    Am J Orthod Dentofacial Orthop; 2009 Mar; 135(3):361-74. PubMed ID: 19268836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating osteoporosis.
    Smith G; Stassen L; Flint S
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interaction between bisphosphonates and human bone: a preliminary study on osteonecrosis sequesters of the jaw.
    Olejnik C; Falgayrac G; Vieillard MH; Maes JM; Penel G
    Bull Group Int Rech Sci Stomatol Odontol; 2011 Sep; 50(1):52-3. PubMed ID: 22750602
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing the adverse effects of bisphosphonate therapy on the jaw.
    Rizzolo D; Sedrak M
    JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
    [No Abstract]   [Full Text] [Related]  

  • 13. Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients.
    Adamo V; Caristi N; Saccà MM; Ferraro G; Arcanà C; Maisano R; Santini D; Tonini G
    Expert Opin Pharmacother; 2008 Jun; 9(8):1351-61. PubMed ID: 18473709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. News on bisphosphonates: but will patterns of use change?
    Garg A
    Dent Implantol Update; 2010 Sep; 21(9):71-2. PubMed ID: 20863016
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warning: bisphosphonates and osteochemonecrosis of the jaws.
    Flint SR; Sharkey S; Galvin S
    J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates and osteonecrosis: potential treatment or serious complication?
    Goytia RN; Salama A; Khanuja HS
    Orthop Clin North Am; 2009 Apr; 40(2):223-34. PubMed ID: 19358907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws.
    Ruggiero SL
    Compend Contin Educ Dent; 2008 Mar; 29(2):96-8, 100-2, 104-5. PubMed ID: 18429424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.